Leading specialist of the University of Basel (Switzerland) heads RUDN research laboratory
Professor Jörg Huwyler is a leading specialist in targeted drug delivery, member of the Swiss Academy of Pharmaceutical Sciences, author of 13 patents, 142 peer-reviewed scientific articles (h-index: 38). One of his innovative publications on the delivery of antitumor agents to the rat brain due to immunoliposomes has been cited more than 650 times.
The expert calls the pharmaceutical technology a translation science, as it very often helps to transfer the results of basic research to clinical applications. Several drugs developed in his Swiss laboratory are used in clinical trials.
The joint team of the scientific laboratory for the study of innovative methods of drug delivery is already participating in the project to increase the bioavailability of the drug for the treatment of AIDS by using hot melt extrusion.
The work is also carried out in the field of creating a combined diagnostic drug that will enable drugs adequate choice and dosage regimen in the treatment of cancer.
One of the goals of RUDN research is the development of individual approaches in the treatment of cancer patients through the use of innovative pharmaceutical technologies and metabolic tools - the transition to personalized medicine.
A specialist in spacecraft movement control analyzed the process of placing vehicle stages, boosters, and other space debris into the so-called disposal orbit and suggested cleaning lower orbits up with a spacecraft that has modules with engine units on board. These modules will attach to space debris objects and move them away. As for the geostationary orbit, a preferable way to clean it up would be a towing spacecraft that transports space debris objects into the disposal orbit.
A biologist from RUDN University studied the development of the immune response in prepubertal male and female animals. According to her, the severity and mortality of infectious and inflammatory diseases at this age depend not on the sex hormones, but mainly on the chromosome set or karyotype.
October 6, the Nobel Committee announced the 2021 Nobel Prize Winners in Chemistry. They were scientists Benjamin List (Germany) and David Macmillan (USA) for new methods of molecular synthesis. RUDN chemists know Professor Liszt personally — in 2019, the researcher came to participate in the university conference.